Physician

Adrian Rivera-Flores, MD

According to 2025 Medicare claims, Adrian Rivera-Flores, MD (NPI: 1861472706) practices family practice in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is OCALA HEALTH PRIMARY CARE LLC (NPI: 1720398456; TIN: 80-0609800) and primary practice location at 34420-3118.

Rivera-Flores' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 285 traditional Medicare patients, billed 5,286 HCPCS/CPT codes, and received $126,088 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,782 prescription claims across 718 beneficiaries totaling $673,886 in drug costs, led by Januvia (Sitagliptin Phosphate). DME data shows 85 claims. Open Payments data shows 28 records totaling $553. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $227,949 to $126,088. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $15,184 and ending at $7,988.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	557	10,667	$227,949
2016	585	11,571	$250,019
2017	602	11,782	$241,778
2018	544	10,501	$217,394
2019	509	9,145	$190,708
2020	435	8,057	$165,769
2021	384	3,233	$139,956
2022	352	4,256	$129,143
2023	299	3,686	$120,460
2024	285	5,286	$126,088

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	774	11,852	$722,215
2016	738	10,314	$725,802
2017	737	10,420	$754,005
2018	752	10,011	$772,383
2019	735	9,559	$782,470
2020	715	9,076	$771,830
2021	705	8,441	$720,781
2022	739	8,683	$746,969
2023	741	9,139	$704,382
2024	718	8,782	$673,886

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	257	634	$9,118
2016	208	505	$7,642
2017	122	300	$3,306
2018	108	263	$4,619
2019	101	275	$4,641
2020	55	152	$2,064
2021	51	146	$1,708
2022	36	120	$2,290
2023	19	114	$2,987
2024	19	85	$1,527

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	197	197	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	263	580	$89
36415	Insertion of needle into vein for collection of blood sample	247	518	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	182	231	$8
81003	Automated urinalysis test	217	337	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Januvia	Sitagliptin Phosphate	115	7,632	$142,208
Tradjenta	Linagliptin	61	3,980	$64,439
Eliquis	Apixaban	50	3,074	$56,627
Ozempic	Semaglutide	35	1,826	$52,643
Xarelto	Rivaroxaban	27	1,770	$29,464

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$880
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	19	35	$576
A4256	Normal, low and high calibrator solution / chips	N	N/R	15	$42
A4259	Lancets, per box of 100	N	N/R	22	$29

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$553	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adrian Rivera-Flores, MD?

Tedicare shows public-source Medicare data for Adrian Rivera-Flores, MD (NPI 1861472706), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Rivera-Flores, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adrian Rivera-Flores, MD?

Adrian Rivera-Flores, MD is linked to OCALA HEALTH PRIMARY CARE LLC (billing NPI 1720398456) in the available physician profile data.

Does Adrian Rivera-Flores, MD have Open Payments data?

Adrian Rivera-Flores, MD has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.